• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identifying better surgical candidates among recursive partitioning analysis class 2 patients who underwent surgery for intracranial metastases.识别接受手术治疗颅内转移的递归分区分析 2 类患者中更好的手术候选者。
World Neurosurg. 2014 Jul-Aug;82(1-2):e267-75. doi: 10.1016/j.wneu.2013.08.031. Epub 2013 Sep 25.
2
A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme.一种基于术前变量预测成人多形性胶质母细胞瘤患者预后的分类系统。
J Neurosurg. 2010 May;112(5):997-1004. doi: 10.3171/2009.9.JNS09805.
3
Recursive partitioning analysis (RPA) classification predicts survival in patients with brain metastases from sarcoma.递归划分分析(RPA)分类可预测肉瘤脑转移患者的生存率。
World Neurosurg. 2014 Dec;82(6):1291-4. doi: 10.1016/j.wneu.2014.07.039. Epub 2014 Aug 4.
4
Reevaluation of surgery for the treatment of brain metastases: review of 208 patients with single or multiple brain metastases treated at one institution with modern neurosurgical techniques.脑转移瘤治疗手术的重新评估:对一家机构采用现代神经外科技术治疗的208例单发或多发脑转移瘤患者的回顾。
Neurosurgery. 2005 May;56(5):1021-34; discussion 1021-34.
5
The utility of modified recursive partitioning analysis class 2 in predicting survival among surgical candidates with intracranial metastases.改良递归分割分析2类在预测颅内转移手术候选者生存率中的效用。
World Neurosurg. 2014 Jul-Aug;82(1-2):e111-3. doi: 10.1016/j.wneu.2013.10.021. Epub 2013 Oct 12.
6
Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.立体定向放射外科单独治疗与手术切除加全脑放疗治疗递归分区分析1级和2级患者的1或2个脑转移瘤的疗效比较
Cancer. 2007 Jun 15;109(12):2515-21. doi: 10.1002/cncr.22729.
7
Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes?脑转移瘤的预后因素:是否应根据递归分区分析(RPA)类别选择患者进行积极治疗?
Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):297-302. doi: 10.1016/s0360-3016(99)00416-2.
8
Gamma knife surgery in brain melanomas: absence of extracranial metastases and tumor volume strongest indicators of prolonged survival.伽玛刀手术治疗脑黑色素瘤:无颅外转移和肿瘤体积是延长生存时间的最强指标。
World Neurosurg. 2011 May-Jun;75(5-6):684-91; discussion 598-603. doi: 10.1016/j.wneu.2010.12.054.
9
Two-year experience of multi-disciplinary team (MDT) outcomes for brain metastases in a tertiary neuro-oncology centre.三级神经肿瘤中心脑转移瘤多学科团队(MDT)治疗效果的两年经验
Br J Neurosurg. 2018 Feb;32(1):53-60. doi: 10.1080/02688697.2017.1368449. Epub 2017 Aug 24.
10
Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.脑转移瘤患者接受立体定向放射治疗后的总生存预后因素及分级系统:依原发部位而异
J Neurosurg. 2008 Dec;109 Suppl:77-86. doi: 10.3171/JNS/2008/109/12/S13.

引用本文的文献

1
Prognostic assessment in patients operated for brain metastasis from systemic tumors.系统肿瘤脑转移患者的预后评估。
Cancer Med. 2023 Jun;12(11):12316-12324. doi: 10.1002/cam4.5928. Epub 2023 Apr 11.
2
The management of elderly patients with brain metastases from breast cancer.老年乳腺癌脑转移患者的管理
Transl Cancer Res. 2020 Jan;9(Suppl 1):S62-S76. doi: 10.21037/tcr.2019.07.31.
3
Contemporary Surgical Management of Deep-Seated Metastatic Brain Tumors Using Minimally Invasive Approaches.采用微创方法对深部转移性脑肿瘤进行的当代外科治疗
Front Oncol. 2018 Nov 28;8:558. doi: 10.3389/fonc.2018.00558. eCollection 2018.

本文引用的文献

1
Postoperative survival in patients with multiple brain metastases.多发脑转移瘤患者的术后生存情况。
Medicina (Kaunas). 2012;48(6):281-5.
2
Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.术后立体定向放射外科治疗脑转移瘤而不进行全脑放疗:术前肿瘤大小的潜在作用。
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):650-5. doi: 10.1016/j.ijrobp.2012.05.027. Epub 2012 Jul 12.
3
A nomogram for individualized estimation of survival among patients with brain metastasis.脑转移瘤患者生存个体化评估的列线图。
Neuro Oncol. 2012 Jul;14(7):910-8. doi: 10.1093/neuonc/nos087. Epub 2012 Apr 27.
4
Gamma knife radiosurgery for resectable brain metastasis.伽玛刀放射外科治疗可切除脑转移瘤。
World Neurosurg. 2013 Sep-Oct;80(3-4):351-8. doi: 10.1016/j.wneu.2012.03.021. Epub 2012 Apr 3.
5
Effect of chemotherapy on survival after whole brain radiation therapy for brain metastases: a single-center retrospective analysis.化疗对全脑放疗后脑转移瘤患者生存的影响:单中心回顾性分析。
J Cancer Res Clin Oncol. 2012 Jul;138(7):1239-47. doi: 10.1007/s00432-012-1198-y. Epub 2012 Mar 23.
6
Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis.单一脑转移治疗中切除术联合全脑放疗与切除术联合全脑放疗加推量的比较
Strahlenther Onkol. 2012 Feb;188(2):143-7. doi: 10.1007/s00066-011-0024-9. Epub 2012 Jan 12.
7
Neurosurgical management of metastases in the central nervous system.中枢神经系统转移瘤的神经外科治疗。
Nat Rev Clin Oncol. 2011 Dec 6;9(2):79-86. doi: 10.1038/nrclinonc.2011.179.
8
Factors influencing survival in patients with breast cancer and single or solitary brain metastasis.影响乳腺癌单发性脑转移患者生存的因素。
Eur J Surg Oncol. 2011 Jul;37(7):635-42. doi: 10.1016/j.ejso.2011.05.002. Epub 2011 Jun 12.
9
Predictors of inpatient death and complications among postoperative elderly patients with metastatic brain tumors.老年转移性脑肿瘤术后患者住院死亡和并发症的预测因素。
Ann Surg Oncol. 2011 Feb;18(2):521-8. doi: 10.1245/s10434-010-1299-2. Epub 2010 Aug 31.
10
Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.立体定向放射外科加强治疗寡转移脑疾病的切除床:挑战辅助全脑放疗的传统
Neurosurg Focus. 2009 Dec;27(6):E7. doi: 10.3171/2009.9.FOCUS09191.

识别接受手术治疗颅内转移的递归分区分析 2 类患者中更好的手术候选者。

Identifying better surgical candidates among recursive partitioning analysis class 2 patients who underwent surgery for intracranial metastases.

机构信息

Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.

Department of Neurosurgery, Johns Hopkins University, Neuro-Oncology Outcomes Laboratory, Baltimore, Maryland, USA.

出版信息

World Neurosurg. 2014 Jul-Aug;82(1-2):e267-75. doi: 10.1016/j.wneu.2013.08.031. Epub 2013 Sep 25.

DOI:10.1016/j.wneu.2013.08.031
PMID:24076052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3995859/
Abstract

OBJECTIVE

The management of patients with brain metastases is typically dependent on their prognosis. Recursive partitioning analysis (RPA) is the most commonly used method for prognosticating survival, but has limitations for patients in the intermediate class. The aims of this study were to ascertain preoperative risk factors associated with survival, develop a preoperative prognostic grading system, and evaluate the utility of this system in predicting survival for RPA class 2 patients.

METHODS

Adult patient who underwent intracranial metastatic tumor surgery at an academic tertiary care institution from 1997 to 2011 were retrospectively reviewed. Multivariate proportional hazards regression analysis was used to identify preoperative factors associated with survival. The identified associations were then used to develop a grading system. Survival as a function of time was plotted using the Kaplan-Meier method, and survival rates were compared using log-rank analyses.

RESULTS

A total of 421 (59%) of 708 patients were RPA class 2. The preoperative factors found to be associated with poorer survival were: male gender (P < 0.0001), motor deficit (P = 0.0007), cognitive deficit (P = 0.0004), nonsolitary metastases (P = 0.002), and tumor size >2 cm (P = 0.003). Patients having 0-1, 2, and 3-5 of these variables were assigned a preoperative grade of A, B, and C, respectively. Patients with a preoperative grade of A, B, and C had a median survival of 17.0, 10.3, and 7.3 months, respectively. These grades had distinct survival times (P < 0.05).

CONCLUSIONS

The present study devised a preoperative grading system that may provide prognostic information for RPA class 2 patients, which may also guide medical and surgical therapies before any intervention is pursued.

摘要

目的

脑转移瘤患者的治疗管理通常取决于其预后。递归分区分析(RPA)是目前预测生存率最常用的方法,但对于中等风险类别的患者存在局限性。本研究旨在确定与生存相关的术前危险因素,建立一种术前预后分级系统,并评估该系统在预测 RPA 2 类患者生存中的作用。

方法

回顾性分析 1997 年至 2011 年在一家学术性三级医疗机构接受颅内转移性肿瘤手术的成年患者。采用多变量比例风险回归分析确定与生存相关的术前因素。然后利用这些关联因素建立一个分级系统。采用 Kaplan-Meier 法绘制生存时间函数,并用对数秩检验比较生存率。

结果

在 708 例患者中,有 421 例(59%)为 RPA 2 类。与生存率较差相关的术前因素包括:男性(P < 0.0001)、运动障碍(P = 0.0007)、认知障碍(P = 0.0004)、非孤立性转移(P = 0.002)和肿瘤直径 >2cm(P = 0.003)。有 0-1、2 和 3-5 个这些变量的患者分别被分配术前 A、B 和 C 级。术前分级为 A、B 和 C 的患者的中位生存时间分别为 17.0、10.3 和 7.3 个月。这些分级具有明显的生存时间差异(P < 0.05)。

结论

本研究制定了一种术前分级系统,可为 RPA 2 类患者提供预后信息,也可在进行任何干预之前指导医疗和手术治疗。